Citation Impact
Citing Papers
Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti–human DEC205 monoclonal antibody
2010 StandoutNobel
Vaccine-delivered HIV envelope inhibits CD4+ T-cell activation, a mechanism for poor HIV vaccine responses
2006 StandoutNobel
Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA
2004 StandoutScience
Plasmacytoid Dendritic Cell Dynamics and Alpha Interferon Production during Simian Immunodeficiency Virus Infection with a Nonpathogenic Outcome
2008 StandoutNobel
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
HIV-1 gp120 Modulates the Immunological Function and Expression of Accessory and Co-Stimulatory Molecules of Monocyte-derived Dendritic Cells
2002
The IL-6 family cytokines, interleukin-6, interleukin-11, oncostatin M, and leukemia inhibitory factor, enhance mast cell growth through fibroblast-dependent pathway in mice
2001
X4 and R5 HIV-1 Have Distinct Post-entry Requirements for Uracil DNA Glycosylase during Infection of Primary Cells
2010 StandoutNobel
Efficient T Cell Activation via a Toll-Interleukin 1 Receptor-Independent Pathway
2006 StandoutNobel
Psoriasis
2009 Standout
Cytokine mRNA Expression in Mononuclear Cells from Different Tissues during Acute SIVmac251 Infection of Macaques
1996
Antibody-Dependent Induction of Type I Interferons by Poliovirus in Human Mononuclear Blood Cells Requires the Type II Fcγ Receptor (CD32)
2000
Interleukin‐10: Potential Benefits and Possible Risks in Clinical Infectious Diseases
1998
Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial
2005
Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole
1991 Standout
Hidradenitis Suppurativa
2012 Standout
Pathogenesis and clinical features of psoriasis
2007 Standout
Phaeochromocytoma
2005 Standout
Interleukin 10 Treatment of Psoriasis
1999
Interferons in the pathogenesis and treatment of human immunodeficiency virus infection
1994
Diagnosis and treatment of psoriatic arthritis
2004
Antibiotic prophylaxis in neutropenic patients
2006
Induction of Interferon-α by Glycoprotein D of Herpes Simplex Virus: A Possible Role of Chemokine Receptors
1998
Interleukin-7: master regulator of peripheral T-cell homeostasis?
2001
Links between innate and adaptive immunity via type I interferon
2002
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
2006 Standout
Psoriasis
2021 Standout
Polymorphisms in Interleukin-15 Gene on Chromosome 4q31.2 Are Associated with Psoriasis Vulgaris in Chinese Population
2007
The interface between innate and adaptive immunity
2004 StandoutNobel
Interleukin-10 Enhances Tumor Necrosis Factor-α Activation of HIV-1 Transcription in Latently Infected T Cells
1998
Increased Serum Tumour Necrosis Factor- in Hidradenitis Suppurativa Patients: Is There a Basis for Treatment with Anti-Tumour Necrosis Factor- Agents?
2009
Membrane vesicles as conveyors of immune responses
2009 Standout
Psoriasis
2015 Standout
Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor- viral RNA interactions
2005
Expression of Activated MEK1 in Differentiating Epidermal Cells Is Sufficient to Generate Hyperproliferative and Inflammatory Skin Lesions
2004
Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat
2005
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
2013 StandoutNobel
Microvesicles Are a Source of Contaminating Cellular Proteins Found in Purified HIV-1 Preparations
1997
Complement
2001 Standout
Clinical pharmacokinetics of TNF antagonists: How do they differ?
2005
Comparison of Somatostatin Analog and Meta-Iodobenzylguanidine Radionuclides in the Diagnosis and Localization of Advanced Neuroendocrine Tumors
2001
Regulation of type I interferon responses
2013 Standout
Complement receptors in HIV infection
1997
The antipsoriatic activity of IL-10 is rather caused by effects on peripheral blood cells than by a direct effect on human keratinocytes
2000
Etanercept as Monotherapy in Patients with Psoriasis
2003
Human natural interferon-α producing cells
1993
Convergent Mechanisms for Recognition of Divergent Cytokines by the Shared Signaling Receptor gp130
2003 StandoutNobel
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
2007 Standout
Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population
2010
Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy
2002
Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies
2006 Standout
Interleukin 1β, Interleukin 6, Tumor Necrosis Factor α, and Interleukin 10 Responses in Peripheral Blood Mononuclear Cells of Cynomolgus Macaques during Acute Infection with SIVmac251
1996
From the Infectious Diseases Society of America: Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever
1990
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
Invasive Methicillin-Resistant <EMPH TYPE="ITAL">Staphylococcus aureus</EMPH> Infections in the United States
2007 Standout
IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach.
1998
Enhanced Interleukin‐10 Production in Response toMycobacterium aviumProducts in Mononuclear Cells from Patients with Human Immunodeficiency Virus Infection
1998
Regulation of chemokine/cytokine network during in vitro differentiation and HIV-1 infection of human monocytes: possible importance in the pathogenesis of AIDS
2000
Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity
1997
The Acquisition of Host-Derived Major Histocompatibility Complex Class II Glycoproteins by Human Immunodeficiency Virus Type 1 Accelerates the Process of Virus Entry and Infection in Human T-Lymphoid Cells
1997
The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood
1999 StandoutScience
Small GTP-Binding Proteins
2001 Standout
IL-7 Stimulates T Cell Renewal Without Increasing Viral Replication in Simian Immunodeficiency Virus-Infected Macaques
2003 StandoutNobel
Antidrug antibodies in psoriasis: a systematic review
2013
Cell-to-Cell Contact Results in a Selective Translocation of Maternal Human Immunodeficiency Virus Type 1 Quasispecies across a Trophoblastic Barrier by both Transcytosis and Infection
2001 StandoutNobel
Human immunodeficiency virus type 1 gp120 induces anergy in human peripheral blood lymphocytes by inducing interleukin-10 production
1996
The Acquisition of Host-Derived Major Histocompatibility Complex Class II Glycoproteins by Human Immunodeficiency Virus Type 1 Accelerates the Process of Virus Entry and Infection in Human T-Lymphoid Cells
1997
Kaposi's Sarcoma-Associated Herpesvirus Virions Inhibit Interferon Responses Induced by Envelope Glycoprotein gpK8.1
2006
APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection
2006 StandoutNobel
Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor
1996
IL-17 and Th17 Cells
2009 Standout
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
2004 StandoutNobel
Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures
2007 Standout
IL-7 Induces Immunological Improvement in SIV-Infected Rhesus Macaques under Antiviral Therapy
2006 StandoutNobel
Increased mutation frequency of feline immunodeficiency virus lacking functional deoxyuridine-triphosphatase.
1995
Interleukin-7 Induces Expression of Latent Human Immunodeficiency Virus Type 1 with Minimal Effects on T-Cell Phenotype
2002
Binding of Human Immunodeficiency Virus Type 1 to CD4 Induces Association of Lck and Raf-1 and Activates Raf-1 by a Ras-Independent Pathway
1996
T Cells Expressing Activated LFA-1 Are More Susceptible to Infection with Human Immunodeficiency Virus Type 1 Particles Bearing Host-Encoded ICAM-1
1998
Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)
2005 StandoutNobel
The Programmed Death-1 and Interleukin-10 Pathways Play a Down-Modulatory Role in LP-BM5 Retrovirus-Induced Murine Immunodeficiency Syndrome
2007 StandoutNobel
Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions
1996
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
HIV-1 Selectively Infects a Subset of Nonmaturing BDCA1-Positive Dendritic Cells in Human Blood
2006 StandoutNobel
Regulation of LFA-1 Activity through Cytoskeleton Remodeling and Signaling Components Modulates the Efficiency of HIV Type-1 Entry in Activated CD4+ T Lymphocytes
2005
Wound Healing: A Cellular Perspective
2018 Standout
Possible Role of Interleukin-10 (IL-10) and CD40 Ligand Expression in the Pathogenesis of Hypergammaglobulinemia in Human Immunodeficiency Virus Infection: Modulation of IL-10 and Ig Production After Intravenous Ig Infusion
1998
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Regulation of Adaptive Immunity by the Innate Immune System
2010 StandoutScience
HIV Gag mRNA Transfection of Dendritic Cells (DC) Delivers Encoded Antigen to MHC Class I and II Molecules, Causes DC Maturation, and Induces a Potent Human In Vitro Primary Immune Response
2000 StandoutNobel
Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection
2004 StandoutNobel
Fcγ Receptor-Mediated Suppression of Human Immunodeficiency Virus Type 1 Replication in Primary Human Macrophages
2003 StandoutNobel
Possible Role of Interleukin-10 (IL-10) and CD40 Ligand Expression in the Pathogenesis of Hypergammaglobulinemia in Human Immunodeficiency Virus Infection: Modulation of IL-10 and Ig Production After Intravenous Ig Infusion
1998
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
The Engagement of Activating FcγRs Inhibits Primate Lentivirus Replication in Human Macrophages
2006 StandoutNobel
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Meta-Analysis: Antibiotic Prophylaxis Reduces Mortality in Neutropenic Patients
2005
Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients
2005 StandoutNobel
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
2020 Standout
Works of F. Ameglio being referenced
IL-1 alpha, IL-1 beta and psoriasis: conflicting results in the literature. Opposite behaviour of the two cytokines in lesional or non-lesional extracts of whole skin.
1998
A Simple and Reliable Method to Detect Cell Membrane Proteins on Infectious Human Immunodeficiency Virus Type 1 Particles
1994
Recombinant Glycoprotein 120 of Human Immunodeficiency Virus is a Potent Interferon Inducer
1992
HIV Type 1 Grown on Interferon γ-Treated U937 Cells Shows Selective Increase in Virion-Associated Intercellular Adhesion Molecule 1 and HLA-DR and Enhanced Infectivity for CD4-Negative Cells
1995
Spontaneous release of leukemia inhibitory factor and oncostatin-M is increased in supernatants of short-term organ cultures from lesional psoriatic skin
1998
Host cell antigenic profile acquired by HIV-1 is a marker of its cellular origin
1995
Decreased Interleukin‐7 and transforming growth factor‐beta1 levels in blister fluids as compared to the respective serum levels in patients with bullous pemphigoid: Opposite behavior of TNF‐alpha, Interleukin‐4 and Interleukin‐10
1998
Correlated increases of tumour necrosis factor-alpha, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients relationships with disease severity
1994
Increased serum interleukin-15 levels in bullous skin diseases: correlation with disease intensity
1999
Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis.
1998
Aerosolized interferon-alpha treatment in patients with multi-drug-resistant pulmonary tuberculosis.
2000
Association between lesional or non lesional S. aureus strains from patients with impetigo and exfoliative toxin production. No association with SmaI PFGE patterns.
2000
Recombinant gp120 induces IL-10 in resting peripheral blood mononuclear cells; correlation with the induction of other cytokines
1994
Amikacin plus ceftazidime versus amikacin plus piperacillin versus amikacin plus aztreonam in infections in neoplastic patients with granulocytopenia.
1987
Induction of interleukin-10 by human immunodeficiency virus type 1 and its gp120 protein in human monocytes/macrophages
1995
Serum IL-10 levels in HIV-positive subjects: correlation with CDC stages.
1995
Bullous pemphigoid and pemphigus vulgaris: correlated behaviour of serum VEGF, sE-selectin and TNF-alpha levels.
1998
IL-10 levels are decreased in psoriatic lesional skin as compared to the psoriatic lesion-free and normal skin suction blister fluids.
1995
Evaluation of the response to chemotherapy in patients affected with small cell lung cancer using discriminant analysis: A preliminary report
1996
Chemoprophylaxis of bacterial infections in granulocytopenic cancer patients using norfloxacin.
1988